Skip to content
value.today

Palmaz Scientific Inc.

🇺🇸 Dallas, Texas, USAHealth CareFounded 2008
Total raised
$28 M
2 rounds on record
Latest round
$1 M
Sep 2014
First round on record
Nov 2010
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Palmaz Scientific Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2014$1 MNo. 2Under $2 million

Palmaz Scientific Inc.: Raise no. 2, Sep 2014

Investors in this round

7 investors had bought by the notice of Sep 23, 2014: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $4 M offered; $3 M still to sell
Smallest investment taken
$50,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$210,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Julio C Palmaz · Executive Officer, Director
  • Steven B Solomon · Executive Officer, Director
  • Eugene A Sprague · Director
  • Philip C Romano · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Merriman Capital, Inc. (CRD 18296) · broker-dealer Jonathan Merriman (CRD 18296) · San Francisco, CaliforniaSold in AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY
  • Emerson Equity LLC (CRD 130032) · broker-dealer Brent Barton (CRD 1659916) · San Mateo, CaliforniaSold in AL, AZ, CA, CO, CT, FL, GA, HI, ID, IL, IN, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NE, NH, NJ, NM, NV, NY, OH, OR, PA, PR, RI, SC, SD, TX, UT, VA, VT, WA, WI, WY
  • Titan Securities (CRD 131392) · broker-dealer Gary Zimpelman (CRD 2025938) · Dallas, TexasSold in AR, AZ, CA, CO, FL, GA, HI, IA, ID, IN, KS, LA, MI, MN, MO, NC, NM, NV, NY, OH, OK, SD, TN, TX, UT, VA, WA, WI, WV, WY

Remarks in the notice

  • On fees: “Assumes the entire $4.2 million is sold and the placement agents receive up to 5% cash commission. The placement agents may also receive warrants to purchase shares of common stock.”
  • On the amounts: “The Series A-1 Preferred Stock Offering is for $3,500,000 plus an over-allotment of $700,000 for a combined total of $4,200,000 being offered.”

Signed by Stven B. Solomon, Ceo. Source: SEC Form D, newest notice filed Sep 23, 2014. Read the notice at the SEC.

equity, optionsSEC
Nov 2010$26 MNo. 1$10 to $50 million

Palmaz Scientific Inc.: Raise no. 1, Nov 2010

Investors in this round

261 investors had bought by the notice of Nov 26, 2013: 261 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$26 M of $30 M offered; $4 M still to sell
Smallest investment taken
$25,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
$3,000,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Julio C Palmaz · Executive Officer, Director
  • Steven B Solomon · Executive Officer, Director
  • Christopher C Banas · Director
  • Philip C Romano · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Jefferies & Company, Inc. (CRD 2347) · New York, New YorkSold in all US states, and outside the US
  • Capital Institutional Services, Inc. (CRD 7551) · Dallas, TexasSold in CA, NY, TX
  • WFG Investments, Inc. (CRD 22704) · Dallas, TexasSold in all US states
  • Titan Securities (CRD 131392) · Dallas, TexasSold in AR, AZ, CA, CO, FL, GA, IA, ID, IN, KS, LA, MA, MI, MN, MO, NC, NM, NV, NY, OH, OK, SC, SD, TX, UT, VA, WA, WI, WV, WY

Remarks in the notice

  • On fees: “Assumes the entire $30 million is sold and the placement agents receive up to 10% cash commission. The placement agents may also receive warrants to purchase shares of common stock.”

Signed by Steven B. Solomon, Ceo. Source: SEC Form D and 5 amendments, newest notice filed Nov 26, 2013. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Palmaz Scientific Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2014).

    SEC Form D · Sep 2014

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Sep 2014

That is all the official record says: Palmaz Scientific Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Palmaz Scientific Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 261 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Palmaz Scientific Inc.
NameRoleNamed in
Julio C PalmazExecutive officerSep 2014
Steven B SolomonExecutive officerSep 2014
Eugene A SpragueDirectorSep 2014
Julio C PalmazDirectorSep 2014
Philip C RomanoDirectorSep 2014
Steven B SolomonDirectorSep 2014
Christopher C BanasDirectorNov 2013